Iriny B.

Iriny B. has an extensive work experience in the field of pharmaceutical research and development. Iriny is currently working as a Principal Scientist at Iambic Therapeutics since October 2021. Prior to that, they worked at Metacrine, Inc. as a Research Scientist II from August 2019 to October 2021, and as a Research Scientist I from April 2019 to August 2021.

Before joining Metacrine, Inc., Iriny B. worked as a Research Scientist at Gossamer Bio from May 2018 to April 2019. Prior to that, they had a long tenure at Dart NeuroScience as a Senior Associate Scientist from October 2011 to February 2018. During their time at Dart NeuroScience, they contributed significantly to various projects, including designing and advancing a lead compound, synthesizing novel compounds, and optimizing synthetic routes.

Iriny B. also gained extensive experience as a Senior Scientist at Pfizer from September 2003 to August 2011. Iriny'sresponsibilities at Pfizer included contributing to projects in different therapeutic areas, designing and synthesizing compounds, and optimizing key reactions. Additionally, they worked as a Research Associate at SUGEN from January 2000 to September 2003, where they made contributions to multiple kinase projects through synthesis, purification, and characterization of novel chemical entities.

Overall, Iriny B. has a diverse background in pharmaceutical research, with experience in project contribution, compound design and synthesis, and optimization of reactions.

Iriny B. attended Alexandria University from 1992 to 1996, where they obtained a Bachelor of Science degree in Chemistry.